Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-062118
Filing Date
2021-10-29
Accepted
2021-10-29 18:09:58
Documents
2
Period of Report
2021-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2128
2 POA DOCUMENT poa.txt EX-24 3070
  Complete submission text file 0001209191-21-062118.txt   6637
Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Paya Carlos V (Reporting) CIK: 0001606244 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39323 | Film No.: 211364638

Mailing Address 353 HATCH DR FOSTER CITY CA 94404
Business Address 353 HATCH DR FOSTER CITY CA 94404 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)